Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CERVO Therapeutics AB
AB
In liquidation
Org 5593144891
Research and experimental development on biotechnology
· NACE 7211
Est. 2021
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on biotechnology
/
CERVO Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JL
Jonny Lennart Greinsmark
Liquidator
Liquidator
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Former (4)
BM
Bertrand Marie René Joseph
Board of Directors
2022 – 2024
BA
Bettina Astrid J Gleiss Joseph
Deputy Board Member
2022 – 2024
MA
Mathilde Annabelle Cheray
Chairman
2022 – 2024
PM
Pedro Miguel Borges Fonseca
Deputy Board Member
2022 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on CERVO Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
